
|Articles|January 1, 2003
Once-daily quinolone effective for uncomplicated UTI
San Diego-A new once-daily formulation of ciprofloxacin (Cipro XR) is equivalent to conventional twice-daily dosing for treatment of uncomplicated urinary tract infections, according to results from a large, multicenter randomized trial. The extended-release formulation was granted FDA approval last month.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Dosing begins in trial of alpha radioligand therapy for mCRPC
2
Estradiol and ADT: Lessons from Lived Experience
3
Mark Tyson, MD, highlights ADVANCED-2 trial in BCG-naïve NMIBC
4
High PHI scores are linked to increased odds of significant prostate cancer
5




















